Source comparison
Growth Hormone Peptides Men Over 40 Vitality: Clinical Outcomes Comparison
GHRP-2 Ghrelin receptor agonist 100–300 mcg nightly 30–60 minutes post-injection +35–50 ng/mL Rapid improvements in sleep quality and recovery; moderate fat loss Hexarelin Ghrelin receptor agonist (higher potency) 100 mcg twice daily 20–45 minutes post-injecti
This comparison does not assign a generated winner or score.
- GHRP-2
- Ghrelin receptor agonist
- 100–300 mcg nightly
- 30–60 minutes post-injection
- +35–50 ng/mL
- Rapid improvements in sleep quality and recovery; moderate fat loss
- Hexarelin
- Ghrelin receptor agonist (higher potency)
- 100 mcg twice daily
- 20–45 minutes post-injection
- +50–70 ng/mL
- Strongest appetite stimulation; significant lean mass gains in 12-week trials
- CJC-1295 (no DAC)
- GHRH analogue
- 100 mcg 2–3× weekly
- 60–120 minutes post-injection
- +25–40 ng/mL
- Sustained baseline GH elevation; works well in combination protocols
- CJC-1295 with DAC
- GHRH analogue (extended half-life)
- 1,000–2,000 mcg weekly
- Continuous over 6–8 days
- +60–90 ng/mL
- Most convenient dosing; ideal for hybrid protocols with ghrelin mimetics
- CJC-1295 + Ipamorelin
- Hybrid (GHRH + ghrelin mimetic)
- 1,000 mcg CJC weekly + 200 mcg Ipamorelin nightly
- Dual: sustained + pulsatile
- +70–110 ng/mL
- Highest IGF-1 response; best overall vitality outcomes in men 40+